Harvard Global Catalyst Win-win initiative

Catalyzing win-win partnerships between stakeholders and interested parties to increase access to Clinical Oncology-Radiotherapy, cancer care and prevention in Low and Middle Income Countries (LMIC)

In 2007, the Win-Win Scientific Initiative was proposed by Ahmed Elzawawy with aim of increasing affordability of better value cancer treatment in the world via exploring scientific approaches. All the stake-holders, particularly cancer patients and their families could win! This also includes flourishing the business of pharmaceutical companies and manufacturers of radiotherapy machines and medical devices without ruining a country of individual economies. In April 2016, the win-win initiative joined the Harvard Global Health Catalyst and became one of its activities.  This highly outcomes oriented session, chaired by Prof Elzawawy, will engage Industry leaders and stakeholders with goal of catalyzing win-win partnerships to increase access to cancer care and prevention in LMIC starting from Africa.

Tentative list  (subject to change) of some of our powerful speakers/panelists : Please Check back soon for updates

Ahmed Elzawawy, MD

Professor, Chair of the Win-win Initiative President of ICEDOC & Immediate Past President of African Organization for Research and Training in Cancer (AORTIC)

Eduardo CAZAP

President of the Latin American & Caribbean Society of Medical Oncology; Past-President Union for International Cancer Control

Paul Nguyen, MD

Associate Professor, Radiation Oncology, Harvard Medical School Director of Prostate Brachytherapy and Clinical Trials for Genitourinary Radiation Oncology, Radiation Oncology, Dana-Farber Cancer Institute

Dr Rasha Kelej

Global Vice President, Merck KGAA Darmstadt Germany

Dow Wilson

President and CEO of Varian Medical Systems

Twalib Ngoma, MD

Professor and Chair, Department of Clinical Oncology, Muhimbili University of Health and Allied Sciences, Tanzania

David Kerr, MD

Professor and Co-Founder AfrOx (Africa Oxford Cancer Foundation) and Professor of Cancer Medicine, Oxford University, Oxford, UK

Nicholas Anthony Othieno-Abinya, MD

Professor of Medicine, head of section of Haematology/Oncology, Department of Clinical Medicine and Therapeutics, University of Nairobi and Kenyatta National Hospital

Riccardo Audisio

Professor of Surgical Oncology, Sweden

Surgical Oncology chair

Dr Krystyna Kiel

 Professor at Rush University Medical Center 

Chicago, USA

Holger Wirtz

Solar-powered Radiotherapy Pioneer Head of medical-physics Chief Technical Officer Of Lake Constance Radiotherapy Center Singen-Friedrichshafen, Germany

Dr. AlvAro Luongo

Director of INCA and Cancer control program, Uruguay